|
Market Closed -
Other stock markets
|
Pre-market 11:19:23 | |||
| 61.82 USD | -2.11% |
|
63.78 | +3.17% |
| 07-16 | Moderna advances its cancer therapy assessment, but the stock slides | |
| 07-16 | Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech -- Update | DJ |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -7.13x | 4.33x | 10.08x | -6.19x | -5.82x | 24.53B | ||
| 0.58% | 0.66% | 17.76x | 2.02x | 3.85x | 10.09x | 11.52x | 68.85B | ||
| 0.61% | 0.63% | 25.64x | 3.88x | 5.3x | 15.59x | 19.32x | 52.13B | ||
| -.--% | -.--% | 34.55x | 6.94x | 11.7x | 22.35x | 26.04x | 43.46B | ||
| 3.31% | 3.4% | -46.16x | 2.53x | 3.26x | 9.62x | 11.22x | 41.24B | ||
| -.--% | -.--% | 24.47x | 1.63x | 3.57x | 11.94x | 13.55x | 30.41B | ||
| -.--% | -.--% | 77.55x | - | - | - | - | 23.42B | ||
| -.--% | 0.05% | 64.32x | 5.78x | 6.31x | 43.41x | 48.98x | 19.75B | ||
| -.--% | -.--% | 24.47x | 3.59x | 5.19x | 13.62x | 18.87x | 16.57B | ||
| -.--% | -.--% | -36.62x | -6.49x | 17.52x | -47.76x | -54.5x | 15.95B | ||
| -.--% | -.--% | -111.49x | 12182.2x | 11.98x | -85.75x | -119.56x | 11.84B | ||
| -.--% | -.--% | 17.66x | - | 3.62x | 14.01x | 16.36x | 11.52B | ||
| -.--% | -.--% | 46.82x | - | - | - | - | 10.46B | ||
| 0.18% | 0.19% | 50.59x | 20.63x | 30.53x | 43.18x | 44.53x | 9.96B | ||
| 2.86% | 3.24% | 11.97x | 1.08x | 1.81x | 7.29x | 9.85x | 6.28B | ||
| 0.37% | 0.44% | 27.66x | - | 7.41x | 19.67x | 23.5x | 5.64B | ||
| -.--% | -.--% | -108.47x | - | - | - | - | 5.33B | ||
| 1.76% | 1.95% | 12.83x | 1.18x | 2.14x | 5.53x | 6.69x | 5.14B | ||
| Average | 0.54% | 0.59% | 7.02x | 940.72x | 8.28x | 5.11x | 4.70x | 22.36B | |
| Weighted average by Cap. | 0.59% | 0.63% | 13.00x | 420.03x | 7.11x | 8.73x | 9.69x |
- Stock Market
- Stocks
- MRNA Stock
- Sector Moderna, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















